Leukemia Trials in Ann Arbor, United States
Conditions / Leukemia / Ann Arbor, United States
Clinical trials for Leukemia investigate a range of treatment strategies and patient populations.
82 total trials for this combination
Showing top 10 of 82 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00004932 | STI571 in Treating Patients With Recurrent Leukemia | COMPLETED | PHASE1 |
| NCT00736749 | Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies | RECRUITING | — |
| NCT00006462 | Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia | COMPLETED | PHASE2 |
| NCT00003593 | Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome | COMPLETED | PHASE3 |
| NCT02012699 | Integrated Cancer Repository for Cancer Research | RECRUITING | — |
| NCT00719563 | American Ginseng in Treating Patients With Fatigue Caused by Cancer | COMPLETED | PHASE3 |
| NCT03452774 | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | RECRUITING | — |
| NCT06578247 | Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML | RECRUITING | — |
| NCT00021242 | Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia | COMPLETED | PHASE2 |
| NCT00003178 | Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia | COMPLETED | PHASE2 |